Ferrochelatase is a therapeutic target for ocular neovascularization. - Wikidata - thesis-toulmin - TriplyDB

Ferrochelatase is a therapeutic target for ocular neovascularization.

Ferrochelatase is a therapeutic target for ocular neovascularization.

http://www.wikidata.org/entity/Q33749012

about

Antiangiogenic effect of dasatinib in murine models of oxygen-induced retinopathy and laser-induced choroidal neovascularization.

P2860

Q47164091-BAFCFE37-C4D4-404A-BD98-70BFB0FF7FAA

P2860

Ferrochelatase is a therapeutic target for ocular neovascularization.

http://www.wikidata.org/entity/Q33749012

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Ferrochelatase is a therapeutic target for ocular neovascularization.

@ast

Ferrochelatase is a therapeutic target for ocular neovascularization.

@en

type

label

Ferrochelatase is a therapeutic target for ocular neovascularization.

@ast

Ferrochelatase is a therapeutic target for ocular neovascularization.

@en

prefLabel

Ferrochelatase is a therapeutic target for ocular neovascularization.

@ast

Ferrochelatase is a therapeutic target for ocular neovascularization.

@en

P1433

Q33749012-674C0200-C34B-4773-9645-F0E96D8CD8ED

P1476

Q33749012-E262BB59-27EA-484D-BF89-54A0CECB372F

P2093

Q33749012-09CF2838-CFCA-45E7-9BAA-378660F8E6C8

Q33749012-18578EB4-CB73-4344-A55B-09A1EACD1155

Q33749012-2F945AF2-687C-4431-944C-760BFC74B11D

Q33749012-3420AA88-73AC-43E2-A749-B2A4F16F3661

Q33749012-61FAD776-4DDD-48FE-B5D1-6DE43BA3EA9E

Q33749012-6744D4CF-2607-4B2C-B1D2-5562503159AE

Q33749012-785408ED-0076-4C5A-BE30-FC5DC65135C4

Q33749012-7D208049-804C-47E9-B5AF-76B13B3F85CC

Q33749012-8E08583F-5627-4925-870D-19BDB1D72549

Q33749012-9A589DCE-D746-473B-83CF-F762B04F7528

P2860

Q33749012-000A04DA-7679-40B6-94B5-D73B472A9CC2

Q33749012-037B4A59-4F64-460A-8249-5FD0289B2432

Q33749012-05D5C38C-3253-470F-B4AF-EEC85219C4FB

Q33749012-1AF38CCF-10CB-4D7C-85EE-7B5B23A7E576

Q33749012-1D209347-D65C-4D34-AF78-C4A0CF7EECF2

Q33749012-1E984207-4027-4F35-9F38-3CF6132F92FD

Q33749012-26C04B31-1C97-4C31-BDB2-5511ADF293C8

Q33749012-2D07C19B-2E8F-46E7-B958-5103DF8041B5

Q33749012-2D9B420F-F214-457D-87B3-E82364600735

Q33749012-2DF56C36-28DE-40D9-A2DA-CF17D7EF5494

P304

Q33749012-708F29DB-009D-40D9-B89C-0F4554C7D5DD

P31

Q33749012-40E77ED1-8518-4751-B7C2-0E7B0AA81C1D

P356

Q33749012-6CBA4FD2-101A-45F2-A74F-658DE7B66F43

P407

Q33749012-11BA2500-AC44-41FC-ACCC-DE7F1FD80A02

P433

Q33749012-73CA96E6-CDEA-4F8B-A425-539AB479FCD2

P478

Q33749012-7B3DC163-6C5F-469E-A721-CE56AEDB3BA3

P50

Q33749012-7CDAB64D-690A-43C9-B9E5-B7133E709CCA

P577

Q33749012-9F369B5F-0B2D-4C00-AB5E-C944C48FE6C8

P698

Q33749012-6C1DDEA2-96A4-47BB-BF30-9EEF8D6EE36F

P921

Q33749012-B8032EA9-432C-4711-92C0-25F86BD002A4

P932

Q33749012-5302A1D0-FB6F-4686-A1B7-303F29C99DBA

P356

P1433

EMBO Molecular Medicine

P1476

Ferrochelatase is a therapeutic target for ocular neovascularization

@en

P2093

Bit Lee

http://www.w3.org/2001/XMLSchema#string

Buyun Tang

http://www.w3.org/2001/XMLSchema#string

Christian M Briggs

http://www.w3.org/2001/XMLSchema#string

Halesha D Basavarajappa

http://www.w3.org/2001/XMLSchema#string

Judith Quigley

http://www.w3.org/2001/XMLSchema#string

Kamakshi L Sishtla

http://www.w3.org/2001/XMLSchema#string

Kamna Gupta

http://www.w3.org/2001/XMLSchema#string

Maria B Grant

http://www.w3.org/2001/XMLSchema#string

Mehdi Shadmand

http://www.w3.org/2001/XMLSchema#string

Michael E Boulton

http://www.w3.org/2001/XMLSchema#string

P2860

Erythropoietic protoporphyria

Application of 4,5-diaminofluorescein to reliably measure nitric oxide released from endothelial cellsin vitro

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Salicylic acid induces mitochondrial injury by inhibiting ferrochelatase heme biosynthesis activity

Mammalian ferrochelatase. Expression and characterization of normal and two human protoporphyric ferrochelatases

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

Synthesis and mechanistic studies of a novel homoisoflavanone inhibitor of endothelial cell growth

Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease

Ferrochelatase structural mutant (Fechm1Pas) in the house mouse

Accumulation of HIF-1alpha under the influence of nitric oxide.

P304

786-801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMMM.201606561

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Timothy W. Corson

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28377496

http://www.w3.org/2001/XMLSchema#string

P921

neovascularization

P932

5452042

http://www.w3.org/2001/XMLSchema#string